Cyclophosphamide as graft-versus-host prophylaxis after allogeneic stem cell transplantation for multiple myeloma. A phase II study.
Latest Information Update: 09 Feb 2023
At a glance
- Drugs Cyclophosphamide (Primary)
- Indications Graft-versus-host disease
- Focus Therapeutic Use
- 09 Feb 2023 Status changed from recruiting to completed.
- 16 Feb 2018 New trial record